Navigation Links
Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
Date:1/5/2012

2 earnings per share to be in the range of $3.10 to $3.20 on both a reported and non-GAAP basis.

The company anticipates 2012 revenue of between $21.8 and $22.8 billion. This includes an expected decline of over $3 billion in Zyprexa sales due to patent expirations in most markets outside of Japan. The reduction in revenue due to Zyprexa patent expirations is expected to be partially offset by growth in key franchises including Cymbalta, Cialis®, Humalog®, Humulin® and Forteo®, as well as continued growth of newer products such as Effient®, Axiron® and Tradjenta®. The company also anticipates continued strong, double-digit revenue growth from its Elanco Animal Health business. Both Japan and Emerging Markets are expected to post continued strong underlying volume growth; however, overall revenue growth in these markets in 2012 will be adversely affected by anticipated pricing actions in Japan and by the expected impact of patent expirations, including Zyprexa, in some emerging market countries.

The company anticipates that gross margin as a percent of revenue will be approximately 77 percent.

As a result of ongoing productivity efforts, the company expects to keep operating expenses essentially flat compared to 2011. Marketing, selling and administrative expenses are expected to be flat to declining and in the range of $7.4 billion to $7.8 billion. Research and development expense is expected to be flat to increasing and in the range of $5.0 billion to $5.3 billion.

Other income and deductions is expected to be in a range between net expense of $50 million and net income of $100 million.

The 2012 tax rate is expected to be approximately 21 percent, and assumes the extension of the R&D tax credit for the full year 2012.

Operating cash flows are expected to be more than sufficient to fund capital expenditures of approximately $800 million, as well as anticipated business development ac
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... 27, 2015 ... sistema di monitoraggio dell,infarto congestizio (CHF - Congestive ...     Vectorious Medical ... sistema per il monitoraggio cardiaco destinato a pazienti ... di aver concluso una raccolta di finanziamenti per ...
(Date:2/27/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today announced ... loss (NOL) guidance and its cash guidance ending the ... financial results were due in large part to the ... from its partners.  Isis, pro forma NOL of $16.3 ... its 2013 NOL of $40.2 million. On a GAAP ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17
(Date:3/1/2015)... CA (PRWEB) March 01, 2015 Comparing ... be possible when using the Quotes Pros portal this ... including United auto insurance rates that are being supplied ... to the updated agencies and prices available for each ... zip code online. Every system user will first be ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 The number ... substantially over the past few weeks in two New ... actively filing claims, the Firm announces. , A ... cases in the Bergen County proceeding established for products ... with a few weeks earlier, when 90 fewer cases ...
(Date:3/1/2015)... February 28, 2015 CrossFit Attollo is a ... are offering a special discount to new members. Now ... for a three month contract will receive their fourth month ... would cost members $440. The three month contract is ... and then the fourth month comes in at only $55. ...
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 people to discover ... “The #1 block was lack of time and ... who created the Thinkubator Innovation Studio in Chicago. ... did not have enough time for innovative thinking and ... , Solutionman’s monthly “Accelerating Innovation Training” workshops address the ...
(Date:2/28/2015)... February 28, 2015 Mew and Company, ... that they now provide business consulting services in addition ... corporate tax planning and succession planning. Company finances are ... experienced professionals. On top of this, complex Canadian tax ... corporate accounting. As a result, Mew and Company works ...
Breaking Medicine News(10 mins):Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2
... Faced with India and China's growing strengths in medical ... creation of a 'global medical excellence cluster' comprising universities ... set up in southeast England to protect Britain's science ... This is the latest of measures initiated by government ...
... of Pennsylvania Health System are starting a trial utilizing ... electrical pulses// essentially short-circuit, referred to as atrial fibrillation ... with current therapies to cope with electrical rhythmic pumping ... is that up until now, they’ve had to deliver ...
... conducted on women in their 70's to observe the relationship ... study followed nearly 12,000 women in// their 70’s over a ... drinks/day for 3-6 days/week, depending on alcoholic content) may lead ... ,This study was published in Journal of the ...
... Pennsylvania’s School of Medicine have found that hospitals with ... little difference in the rate of death for three ... measures may not accurately reflect patient outcomes. Senior author ... at the University of Pennsylvania, Core Investigator with the ...
... leader Sri Sri Ravi Shankar will set up a ... "amalgamation of science and spirituality". ,Yezdi Batliwala of ... the educational wing of the Art of Living foundation, ... the secretary of the state's higher education department, for ...
... major study results from African trials have shown that Circumcision ... 50%. The results are consistent with a similar clinical trial ... surgical removal of foreskin from the penis offered up to ... financed the two studies from Kenya and Uganda, which compared ...
Cached Medicine News:Health News:Britain Plans Medical Hub To Meet India, China Challenge 2Health News:New Tool Being Tested to Halt Recurrence of Atrial Fibrillation 2Health News:Hospital Performance Measures May Not Make Much Difference When It Comes to Mortality 2
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
The Uromac Petite data processor, transducers and Powerbook® computer can be disassembled quickly and easily for travel to multiple sites, providing a very flexible and portable urodynamics syste...
... by Laborie, a leading producer ... credible tracings. ICS recognized Urodynamics ... parameters. Designed especially for the ... to be quick, efficient and ...
... The wireless TRITON™ offers ultimate flexibility ... of the computer, printer and display. Wall-mount ... wireless system by choosing a laptop, touch ... Incorporating the latest technology, this multi-function patient ...
Medicine Products: